当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析

艾德生物

(300685)

  

流通市值:89.30亿  总市值:89.74亿
流通股本:3.90亿   总股本:3.92亿

艾德生物(300685)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.89亿元,每股收益0.48元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益188566.32万元,未分配利润125300.91万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产219382.28万元,负债30815.96万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入579,344,557.65272,090,793.911,108,948,700.11847,967,831.38
营业总成本358,787,743.26171,878,070.83793,982,033.11596,597,050.32
其他经营收益
营业利润222,738,181.68102,082,811.41292,977,984.44253,203,509.67
利润总额219,509,851.42101,793,500.12289,880,662.35251,106,645.91
净利润189,037,382.9690,471,778.52254,863,444.95227,270,537.49
每股收益
其他综合收益56,175.38--204,431.2456,809.94
综合收益总额189,093,558.3490,471,778.52254,659,013.71227,327,347.43
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,920,009,529.971,891,421,886.641,788,399,896.771,743,106,265.64
非流动资产:
非流动资产合计273,813,226.65272,090,942.66276,401,814.29292,488,754.95
资产总计2,193,822,756.622,163,512,829.32,064,801,711.062,035,595,020.59
流动负债:
流动负债合计225,025,173.42219,200,547.05194,822,578.72216,318,964.7
非流动负债:
非流动负债合计83,134,401.2725,465,308.7126,714,374.4810,815,257.35
负债合计308,159,574.69244,665,855.76221,536,953.2227,134,222.05
所有者权益(或股东权益):
归属于母公司股东权益合计1,885,663,181.931,918,846,973.541,843,264,757.861,808,460,798.54
股东权益合计1,885,663,181.931,918,846,973.541,843,264,757.861,808,460,798.54
负债和股东权益合计2,193,822,756.622,163,512,829.32,064,801,711.062,035,595,020.59
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计577,134,919.71290,859,140.411,171,890,950.61847,590,799.87
经营活动现金流出小计406,551,636.56187,604,287.57830,045,352.53607,308,290.22
经营活动产生的现金流量净额170,583,283.15103,254,852.84341,845,598.08240,282,509.65
投资活动产生的现金流量:
投资活动现金流入小计203,395,060.45-594,769,964.09409,688,603.15
投资活动现金流出小计234,630,370.7114,710,740.54668,069,311.36440,118,116.56
投资活动产生的现金流量净额-31,235,310.25-114,710,740.54-73,299,347.27-30,429,513.41
筹资活动产生的现金流量:
筹资活动现金流入小计65,129,357.98-249,405-
筹资活动现金流出小计172,727,465.5117,678,780.49159,889,765.02152,792,895.22
筹资活动产生的现金流量净额-107,598,107.53-17,678,780.49-159,640,360.02-152,792,895.22
汇率变动对现金及现金等价物的影响9,345,925.352,606,466.465,478,078.36-5,173,858.92
现金及现金等价物净增加额41,095,790.72-26,528,201.73114,383,969.1551,886,242.1
期末现金及现金等价物余额356,557,626.54288,933,634.09315,461,835.82252,964,108.77
补充资料:
现金及现金等价物的净增加额41,095,790.72-114,383,969.15-
最新报告期:2025-08-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国信证券张超0.810.981.152025-08-12
东方证券伍云飞0.830.991.202025-07-31
中金公司俞波,张琎,陈诗雨0.831.00--2025-07-29
光大证券王明瑞,黎一江0.880.971.092025-07-29
TOP↑